The Patent Finder

Synthorx, Inc.

Also on record
Records under this name other than patents Synthorx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Synthorx, Inc.

PatentTitleStatus Expires Confidence
US 12,319,944Incorporation of Unnatural Nucleotides and Methods Thereof
now held by Sanofi
In force
 · Medium confidence
In forceMedium confidence
US 10,610,571Cytokine Conjugates for the Treatment of Proliferative and Infectious Diseases
now held by Sanofi
In force
 · Medium confidence
In forceMedium confidence
US 11,622,993Cytokine Conjugates for the Treatment of Autoimmune Diseases
now held by Sanofi
In force
 · High confidence
In forceHigh confidence
US 11,701,407Cytokine Conjugates for the Treatment of Proliferative and Infectious Diseases
now held by Sanofi
In force
 · Low confidence
In forceLow confidence
US 12,318,431Cytokine Conjugates for the Treatment of Proliferative and Infectious Diseases
now held by Sanofi
In force
 · Medium confidence
In forceMedium confidence
US 11,834,689Incorporation of Unnatural Nucleotides and Methods Thereof
now held by Sanofi
In force
 · Medium confidence
In forceMedium confidence
US 12,377,131Cytokine Conjugates for the Treatment of Autoimmune Diseases
now held by Sanofi
In force
 · High confidence
In forceHigh confidence
US 11,077,195IL-2 Conjugates and Methods of Use Thereof
now held by Sanofi
In force
 · High confidence
In forceHigh confidence
US 11,919,934IL-15 Conjugates and Uses Thereof
now held by Sanofi
In force
 · High confidence
In forceHigh confidence
US 12,344,648Novel IL-15 Conjugates and Uses Thereof
now held by Sanofi
In force
 · High confidence
In forceHigh confidence
10 of 42 records shown.
Pro members see all 42.
Pro members: see all 42 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited